KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Equity Ratio (2019 - 2025)

Aurinia Pharmaceuticals (AUPH) has disclosed Equity Ratio for 6 consecutive years, with 0.69 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Equity Ratio fell 1.83% year-over-year to 0.69, compared with a TTM value of 0.69 through Sep 2025, down 1.83%, and an annual FY2024 reading of 0.69, down 0.59% over the prior year.
  • Equity Ratio was 0.69 for Q3 2025 at Aurinia Pharmaceuticals, up from 0.67 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.88 in Q4 2021 and bottomed at 0.67 in Q2 2025.
  • Average Equity Ratio over 5 years is 0.76, with a median of 0.71 recorded in 2024.
  • The sharpest move saw Equity Ratio grew 4.72% in 2022, then decreased 19.91% in 2023.
  • Year by year, Equity Ratio stood at 0.88 in 2021, then dropped by 2.34% to 0.86 in 2022, then fell by 19.91% to 0.69 in 2023, then decreased by 0.59% to 0.69 in 2024, then rose by 1.14% to 0.69 in 2025.
  • Business Quant data shows Equity Ratio for AUPH at 0.69 in Q3 2025, 0.67 in Q2 2025, and 0.69 in Q1 2025.